(PharmaNewsWire.Com, April 16, 2021 ) The Flexible and Semi-rigid Ureteroscopy Market size was used in the top-down approach to estimate the sizes of other individual sub-markets (mentioned in the market segmentation—by type, application, end user, and region) through percentage splits from secondary and primary research. National Institutes of Health, Canadian Urological Association, American Urology Association, Association of Clinical Urologists, European Association of Urology, British Association of Urological Surgeons, Centers for Disease Control and Prevention (CDC), World Bank, and Centers for Disease Control and Prevention (CDC) have been used to identify and collect information useful for this extensive commercial study of the flexible & semi-rigid ureteroscopy industry.
According to the new market research report “Flexible and Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) – Global Forecast” published by MarketsandMarkets™
Expected Revenue Surge: The global semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million, at a CAGR of 5.4%
The semi-rigid ureteroscopy market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region. Asia is expected to grow at the highest CAGR in the flexible & semi-rigid ureteroscopy market during the forecast period. Growth in this region is mainly due to the large patient population.
Leading Key-Players:
Some of the major players operating in ureteroscopy market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).
Olympus (Japan) accounted for the largest share of the flexible & semi-rigid ureteroscopy market. The company has reported an increase in sales in overseas markets, including important emerging markets such as Central and South America, China, Russia, and the Middle East. Olympus focuses on leveraging its competitive flexible ureteroscopes to expand its share and sales. The company invests heavily in research activities. In 2017, it invested ~10% of its total revenue in R&D to enhance product development. It also has a strong brand image and wide geographic presence in the market.
Stryker (US) accounted for the second-largest share of the flexible & semi-rigid ureteroscopy market in 2017. The company strengthened its position in this market by offering high-quality, advanced products to end users. The R&D expenditure of the company increased from USD 715 million in 2016 to USD 787 million in 2017. This increased spending on R&D activities enhances the company’s product development capabilities.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
